Home » Food and nutrition » News Digest #263 – SynBio in India + Ginkgo’s $90m new spin-out Motif takes on food tech

News Digest #263 – SynBio in India + Ginkgo’s $90m new spin-out Motif takes on food tech




 

SynBioBeta Digest

News, trends, and stories from the synthetic biology industry

Hi all,

Two quick program notes, then the news:

Can synthetic biology’s favorite unicorn help change the way we eat for the better? Ginkgo Bioworks just announced the largest-ever Series A in food tech history with the launch of Motif Ingredients, a spin-out that aims to provide next-generation alternative proteins and other ingredients to food companies worldwide.

Jonathan McIntyre, Motif Ingredient’s CEO

This week we focus on India, the second most populous nation in the world with 1.4 billion people, most of whom stand to gain a lot from synthetic biology applications for sustainability. Yet synthetic biology research is still in its infancy in India, mostly confined to a few institutes and groups. We spoke with Dr. Ravi Ramanathan, a research scientist at the Indian Institute of Technology (IIT) in Madras, who is working to democratize tools for biotech research. Find out the three critical bottlenecks he sees blocking the growth and advancement of synthetic biology in India.

India’s largest private company, Reliance Industries Limited (RIL), is at the forefront of the synthetic biology scene there: they have designed novel metabolic pathways in E. coli and Clostridium, enabling the microbes to produce high value biochemicals from waste sugars and syngas. RIL is also actively exploring algae-based strategies for a cleaner planet.

Sustainable agriculture is an important focus of government dollars in India. String Bio is using greenhouse gas to mitigate world hunger by making protein from methane. The protein is only used in animal feed today, but further refinement to make it suitable for human consumption is ongoing.

China is another emerging synthetic biology market we recently examined. Led by Gryphon Scientific, the U.S.-China Economic and Security Review Commission just published a detailed report looking at the development of China’s biotechnology industry and the role foreign trade, investment, and other linkages—particularly with the United States—have played in its evolution.

Looking ahead to SynBioBeta 2019, I’m excited to announce several new partners at the forefront of the field:

  • Geltor creates designer collagen and other high-value protein technologies that deliver unprecedented functionality and benefits.
  • RIL (Reliance Industries Limited) creates strategies to power a clean planet in areas as diverse as organic waste to kerosene and aviation fuel, Jatropha to aviation fuel and biodiesel, and algae to bio-crude and chemicals.
  • Integrated DNA Technologies develops, manufactures, and markets nucleic acid products for the life sciences industry
  • Conagen is using synthetic biology tools to design metabolic pathways, improve production organisms and optimize production procedures for the food, nutrition, flavor and fragrance, pharmaceutical, and renewable materials industries.
I’m also proud to announce these newly confirmed speakers:

Register before March 15th for the best price available.

Have a great week!
John

Latest news

Four new DNA letters double life’s alphabet

Read more →

The race for enzymatic DNA synthesis heats up

Read more →

“Why I believe in cell-free biology” – Zachary Sun

Read more →

BiomX nets $32M to engineer bacteria-killing viruses for IBD and acne

Read more →

Synthego to award $1M in CRISPR tools to genome innovators

Read more →

Lygos to create sustainable performance polymers for sports gear and lightweight materials

Read more →

More reads

More reads

DNA Script announces world’s first enzymatic synthesis of a high-purity 200-nucleotide strand of DNA (Press release) 

CRISPR is being used to treat a patient with a dangerous blood disease (MIT Tech Review)

Autolus taps Vineti to help deliver personalized cell therapies (Fierce Biotech)

Gene-edited high-oleic soybeans out of the lab, into the field (Successful Farming)

Joint venture between Royal DSM and Roquette, Reverdia, will be dissolved (Il Bioeconomista)

Macquarie University to lead nation in synthetic biology research with $2.5m grant

Ginkgo Creative Residency seeks proposals that explore how to re-design a world without waste

Register now for the Cold Spring Harbor Laboratory Synthetic Biology Course, July 23 – August 5, 2019

Profiles in Innovation: Twist Bioscience’s Co‑Founder navigates company from start‑up to public company (Orrick)

Gene-edited animal creators look beyond US market (Nature)

Pheronym secures $100k grant for first ever agriculture bio-control experiment in space

BioBuilder Educational Foundation is offering Synthetic Biology – Professional Development Workshops for STEM teachers

Biome Bioplastics and Futamura partner to demonstrate compostable multilayer packaging

Emerging opportunities and jobs in the bioeconomy (NC State News)

Who's hiring?

Who’s hiring?

Senior Strain Engineer: Bondi Bioworks – Sydney, Australia

Research Associate (CRISPR): Mammoth Biosciences, San Francisco CA

Senior Analytical Chemist / Biochemical Engineer: Bondi Bioworks – Sydney, Australia

Fermentation Research Associate: Conagen, Bedford, MA

Analytical Scientist: Conagen, Bedford, MA

Scientist/ Scientist Associate – Natural Product Downstream Purification & Analysis: Conagen, Bedford, MA

Scientist (CRISPR): Mammoth Biosciences, San Francisco CA

Strain Engineer / Molecular Biologist: Bondi Bioworks – Sydney, Australia

Senior Synthetic Biology Scientist: Rejuvenate Bio, San Diego, CA

Sr. Research Associate/Scientist – Microbial Synthetic Biology: Conagen, Bedford, MA

Automation Associate – Synthetic Biology Automation: Conagen, Bedford, MA

Automation Engineer – Synthetic Biology Automation: Conagen, Bedford, MA

Feature your job here →

 

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up